Overview

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

Status:
RECRUITING
Trial end date:
2029-07-02
Target enrollment:
Participant gender:
Summary
A Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Phase:
PHASE2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
avelumab
Mass Screening